Pure Global

Insulin growth hormone IGBP-3 - Taiwan Registration 8a31527ed05929e27178ff0005b78d0a

Access comprehensive regulatory information for Insulin growth hormone IGBP-3 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8a31527ed05929e27178ff0005b78d0a and manufactured by DIAGNOSTIC SYSTEMS LABORATORIES, INC.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
8a31527ed05929e27178ff0005b78d0a
Registration Details
Taiwan FDA Registration: 8a31527ed05929e27178ff0005b78d0a
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Insulin growth hormone IGBP-3
TW: ๅธธ็›ˆ่ƒฐๅณถ็ด ็”Ÿ้•ทๆฟ€็ด IGBP-3
Risk Class 2
Cancelled

Registration Details

8a31527ed05929e27178ff0005b78d0a

DHA00601619804

Company Information

United States

Product Details

Quantitative determination of IGFBP-3 in serum.

A Clinical chemistry and clinical toxicology

A.1370 Human Growth Hormone Testing System

import

Dates and Status

Mar 22, 2006

Mar 22, 2011

Nov 26, 2012

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ